Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $3.577B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | 2,375,000 | $231M | 6.5% | $94.99 | +8.4% | COM | 76155X100 |
| BMRN | BioMarin Pharmaceutical Inc | 3,575,000 | $202M | 5.6% | $56.00 | +4.8% | COM | 09061G101 |
| ABVX | Abivax SA | 1,500,000 | $167M | 4.7% | $108.56 | — | SPONSORED ADS | 00370M103 |
| NBIX | Neurocrine Biosciences Inc | 1,250,000 | $165M | 4.6% | $134.33 | 0.0% | COM | 64125C109 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,275,000 | $143M | 4.0% | $59.12 | +11.2% | COM | 04280A100 |
| ELVN | Enliven Therapeutics Inc | 3,250,000 | $127M | 3.6% | $19.91 | +28.6% | COM | 29337E102 |
| RGEN | Repligen Corp | 925,000 | $109M | 3.0% | $149.62 | +1.9% | COM | 759916109 |
| BCAX | Bicara Therapeutics Inc | 5,425,000 | $108M | 3.0% | $14.83 | +9.8% | COM | 055477103 |
| NRIX | Nurix Therapeutics Inc | 6,500,000 | $101M | 2.8% | $14.20 | +22.1% | COM | 67080M103 |
| APGE | Apogee Therapeutics Inc | 1,100,000 | $92.59M | 2.6% | $58.03 | +24.5% | COM | 03770N101 |
| ASND | Ascendis Pharma A/S | 375,000 | $85.77M | 2.4% | $206.13 | — | SPONSORED ADR | 04351P101 |
| IMCR | Immunocore Holdings PLC | 2,766,868 | $83.42M | 2.3% | $31.11 | — | ADS | 45258D105 |
| TSHA | Taysha Gene Therapies Inc | 18,000,000 | $80.46M | 2.2% | $4.10 | +16.0% | COM SHS | 877619106 |
| DYN | Dyne Therapeutics Inc | 4,000,000 | $72.52M | 2.0% | $16.97 | +0.9% | COM | 26818M108 |
| SNY | Sanofi SA | 1,400,000 | $67.45M | 1.9% | $48.18 | — | SPONSORED ADR | 80105N105 |
| BCRX | BioCryst Pharmaceuticals Inc | 7,025,000 | $66.88M | 1.9% | $7.07 | -1.0% | COM | 09058V103 |
| SRRK | Scholar Rock Holding Corp | 1,324,422 | $65.11M | 1.8% | $41.27 | +10.2% | COM | 80706P103 |
| IMTX | Immatics NV | 6,175,000 | $60.76M | 1.7% | $9.24 | +6.2% | SHS | N44445109 |
| BMY | Bristol-Myers Squibb Co | 1,000,000 | $60.65M | 1.7% | $54.95 | +4.5% | COM | 110122108 |
| ALC | Alcon AG | 800,000 | $60.28M | 1.7% | $86.36 | -6.8% | ORD SHS | H01301128 |
| GLUE | Monte Rosa Therapeutics Inc | 3,603,465 | $59.28M | 1.7% | $17.36 | +19.0% | COM | 61225M102 |
| VERA | Vera Therapeutics Inc | 1,368,159 | $55.04M | 1.5% | $40.75 | +10.4% | CL A | 92337R101 |
| TERN | Terns Pharmaceuticals Inc | 1,000,000 | $52.72M | 1.5% | $23.11 | +62.1% | COM | 880881107 |
| GMED | Globus Medical Inc | 610,520 | $52.6M | 1.5% | $62.94 | +44.8% | CL A | 379577208 |
| BSX | Boston Scientific Corp | 800,000 | $50.2M | 1.4% | $85.82 | 0.0% | COM | 101137107 |
| NUVL | Nuvalent Inc | 481,715 | $49.35M | 1.4% | $102.01 | +1.6% | COM | 670703107 |
| COGT | Cogent Biosciences Inc | 1,230,888 | $47.38M | 1.3% | $37.37 | 0.0% | COM | 19240Q201 |
| ANRO | Alto Neuroscience Inc | 2,064,075 | $46.4M | 1.3% | $12.14 | +38.1% | COM SHS | 02157Q109 |
| RAPP | Rapport Therapeutics Inc | 1,436,229 | $44.94M | 1.3% | $21.20 | +31.3% | COM | 75383L102 |
| IRON | Disc Medicine Inc | 700,000 | $44.76M | 1.3% | $65.10 | +13.7% | COM | 254604101 |
| UTHR | United Therapeutics Corp | 75,000 | $44.47M | 1.2% | $480.44 | 0.0% | COM | 91307C102 |
| CLDX | Celldex Therapeutics Inc | 1,224,165 | $38.83M | 1.1% | $20.58 | +23.5% | COM NEW | 15117B202 |
| KALV | KalVista Pharmaceuticals Inc | 1,850,000 | $37.24M | 1.0% | $12.75 | +21.5% | COM | 483497103 |
| XENE | Xenon Pharmaceuticals Inc | 639,900 | $37.21M | 1.0% | $37.52 | +11.9% | COM | 98420N105 |
| SLDB | Solid Biosciences Inc | 5,000,000 | $36M | 1.0% | $6.44 | -6.0% | COM NEW | 83422E204 |
| DRUG | Bright Minds Biosciences Inc | 492,319 | $35.92M | 1.0% | $84.00 | 0.0% | COM NEW | 10919W405 |
| PTGX | Protagonist Therapeutics Inc | 326,159 | $34.38M | 1.0% | $83.28 | 0.0% | COM | 74366E102 |
| DNLI | Denali Therapeutics Inc | 1,773,326 | $34.05M | 1.0% | $18.91 | +3.8% | COM | 24823R105 |
| REGN | Regeneron Pharmaceuticals Inc | 40,000 | $30.91M | 0.9% | $769.15 | 0.0% | COM | 75886F107 |
| WAT | Waters Corp | 100,000 | $29.78M | 0.8% | $367.10 | 0.0% | COM | 941848103 |
| VKTX | Viking Therapeutics Inc | 914,147 | $29.75M | 0.8% | $31.35 | 0.0% | COM | 92686J106 |
| INSP | Inspire Medical Systems Inc | 539,269 | $27.82M | 0.8% | $77.43 | 0.0% | COM | 457730109 |
| CBIO | Crescent Biopharma Inc | 1,500,000 | $27.55M | 0.8% | $12.74 | -13.2% | COM | G2545C104 |
| TRVI | Trevi Therapeutics Inc | 2,166,504 | $25.85M | 0.7% | $10.94 | 0.0% | COM | 89532M101 |
| LXEO | Lexeo Therapeutics Inc | 4,475,000 | $25.69M | 0.7% | $7.30 | +3.2% | COM | 52886X107 |
| SLNO | Soleno Therapeutics Inc | 730,000 | $24.44M | 0.7% | $41.63 | 0.0% | COM | 834203309 |
| BBNX | Beta Bionics Inc | 2,211,518 | $22.16M | 0.6% | $16.38 | +4.4% | COM | 08659B102 |
| NKTR | Nektar Therapeutics | 285,000 | $20.51M | 0.6% | $48.33 | 0.0% | COM NEW | 640268306 |
| CYTK | Cytokinetics Inc | 300,000 | $19.77M | 0.6% | $64.44 | 0.0% | COM NEW | 23282W605 |
| AZN | AstraZeneca PLC | 100,000 | $19.72M | 0.6% | $190.39 | 0.0% | ORD | G0593M107 |
| WST | West Pharmaceutical Services I | 75,000 | $18.8M | 0.5% | $251.95 | 0.0% | COM | 955306105 |
| GEHC | GE HealthCare Technologies Inc | 250,000 | $17.8M | 0.5% | $82.25 | 0.0% | COMMON STOCK | 36266G107 |
| SGP | SpyGlass Pharma Inc | 666,760 | $17.28M | 0.5% | $25.91 | — | COM SHS | 85220G109 |
| ZBH | Zimmer Biomet Holdings Inc | 190,000 | $17.18M | 0.5% | $93.96 | -2.5% | COM | 98956P102 |
| MDGL | Madrigal Pharmaceuticals Inc | 31,468 | $16.47M | 0.5% | $492.48 | 0.0% | COM | 558868105 |
| WGS | GeneDx Holdings Corp | 250,000 | $16.05M | 0.4% | $101.12 | 0.0% | COM CL A | 81663L200 |
| GLTO | Damora Therapeutics Inc | 600,000 | $15.54M | 0.4% | $25.80 | 0.0% | COM NEW | 36322Q206 |
| AGIO | Agios Pharmaceuticals Inc | 450,000 | $15.22M | 0.4% | $33.84 | -17.1% | COM | 00847X104 |
| ENGN | enGene Therapeutics Inc | 2,165,000 | $14.74M | 0.4% | $8.82 | +9.6% | COM | 29286M105 |
| SVRA | Savara Inc | 2,600,052 | $14.2M | 0.4% | $4.76 | +19.7% | COM | 805111101 |
| TARS | Tarsus Pharmaceuticals Inc | 200,000 | $14.03M | 0.4% | $69.71 | 0.0% | COM | 87650L103 |
| VYGR | Voyager Therapeutics Inc | 3,002,936 | $11.59M | 0.3% | $5.14 | — | COM | 92915B106 |
| PODD | Insulet Corp | 50,601 | $10.62M | 0.3% | $264.39 | 0.0% | COM | 45784P101 |
| TECX | Tectonic Therapeutic Inc | 328,000 | $10.14M | 0.3% | $18.58 | +13.5% | COM | 878972108 |
| SRZN | Surrozen Inc | 338,611 | $9.864M | 0.3% | $22.23 | 0.0% | COM NEW | 86889P208 |
| ARVN | Arvinas Inc | 905,465 | $9.598M | 0.3% | $12.57 | 0.0% | COM | 04335A105 |
| MPLT | MapLight Therapeutics Inc | 420,000 | $8.539M | 0.2% | $16.83 | +4.7% | COM | 56565P103 |
| FULC | Fulcrum Therapeutics Inc | 1,100,000 | $8.437M | 0.2% | $10.20 | +1.7% | COM | 359616109 |
| OKUR | OnKure Therapeutics Inc | 1,839,819 | $7.617M | 0.2% | $7.01 | -61.1% | COM CL A | 68277Q105 |
| MYGN | Myriad Genetics Inc | 1,648,000 | $7.416M | 0.2% | $6.31 | -13.4% | COM | 62855J104 |
| OLMA | Olema Pharmaceuticals Inc | 428,551 | $6.39M | 0.2% | $17.79 | +43.1% | COM | 68062P106 |
| AVR | Anteris Technologies Global Co | 1,144,780 | $6.354M | 0.2% | $5.58 | 0.0% | COM | 03675P102 |
| QURE | uniQure NV | 358,996 | $5.87M | 0.2% | $23.55 | 0.0% | SHS | N90064101 |
| CADL | Candel Therapeutics Inc | 1,125,000 | $5.513M | 0.2% | $5.74 | 0.0% | COM | 137404109 |
| PALI | Palisade Bio Inc | 2,500,000 | $4.375M | 0.1% | $1.78 | 0.0% | COM | 696389402 |
| VCYT | Veracyte Inc | 130,687 | $4.209M | 0.1% | $39.32 | 0.0% | COM | 92337F107 |
| ZBIO | Zenas Biopharma Inc | 200,000 | $3.91M | 0.1% | $21.89 | 0.0% | COM | 98937L105 |
| GERN | Geron Corp | 2,540,000 | $3.785M | 0.1% | $3.11 | -51.4% | COM | 374163103 |
| MNPR | Monopar Therapeutics Inc | 65,418 | $3.584M | 0.1% | $62.79 | 0.0% | COM NEW | 61023L207 |
| ZURA | Zura Bio Ltd | 511,000 | $3.04M | 0.1% | $5.88 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| NVCR | Novocure Ltd | 250,000 | $2.725M | 0.1% | $13.24 | -5.0% | ORD SHS | G6674U108 |
| NYXH | Nyxoah SA | 868,661 | $2.536M | 0.1% | $8.73 | -45.7% | SHS | B6S7WD106 |
| URGN | UroGen Pharma Ltd | 139,079 | $2.501M | 0.1% | $20.84 | 0.0% | COM | M96088105 |
| PASG | Passage Bio Inc | 305,000 | $2.394M | 0.1% | $6.96 | +72.0% | COM NEW | 702712209 |
| TYRA | Tyra Biosciences Inc | 54,000 | $2.068M | 0.1% | $14.73 | +105.4% | COM | 90240B106 |
| RGNX | REGENXBIO Inc | 108,525 | $909K | 0.0% | $11.87 | -2.3% | COM | 75901B107 |
| TENX | Tenax Therapeutics Inc | 53,439 | $854K | 0.0% | $3.62 | +272.6% | COM NEW | 88032L605 |
| MGNX | MacroGenics Inc | 280,000 | $809K | 0.0% | $14.22 | -87.6% | COM | 556099109 |
| ABSI | Absci Corp | 232,219 | $697K | 0.0% | $3.00 | 0.0% | COM | 00091E109 |
| APRE | Aprea Therapeutics Inc | 350,000 | $267K | 0.0% | $0.78 | 0.0% | COM NEW | 03836J201 |